Jones, RupertMartin, JessicaThomas, VickySkinner, DerekMarshall, Jonathand'Alcontres, Martina StagnoPrice, David2017-08-182017-08-182017-08-17Jones, R, Martin, J, Thomas, V, Skinner, D, Marshall, J, d'Alcontres, M S & Price, D 2017, 'The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD : a UK database study', International journal of chronic obstructive pulmonary disease , vol. 12, pp. 2445-2454. https://doi.org/10.2147/COPD.S1414091176-9106http://hdl.handle.net/2164/9165The study was funded with institutional support from Mundipharma International Limited. Study design, analysis, and data interpretation were reviewed independently by all authors.10763718engSDG 3 - Good Health and Well-beingCOPDinhaler typeexacerbationspneumoniadiabetesdose-responseinhaled steroid/LABA combinationR Medicine (General)R1The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD : a UK database studyJournal article10.2147/COPD.S14140912